Deciphera Pharmaceuticals Inc

NASDAQ:DCPH   3:59:57 PM EDT
16.40
+0.63 (+4.00%)
Earnings Announcements

Deciphera Pharma Reports Q2 2022 Financial Results

Published: 08/04/2022 11:43 GMT
Deciphera Pharmaceuticals Inc (DCPH) - Deciphera Pharmaceuticals, Inc. Announces Second Quarter 2022 Financial Results.
Deciphera Pharmaceuticals Inc - Qtrly Total Revenues $32.5 Million Versus $23.6 Million.
Deciphera Pharmaceuticals Inc - Qtrly Net Loss per Share $0.6.
Revenue is expected to be $33.08 Million
Adjusted EPS is expected to be -$0.57

Next Quarter Revenue Guidance is expected to be $34.85 Million
Next Quarter EPS Guidance is expected to be -$0.56

More details on our Analysts Page.